CCL2, a chemokine, has been shown to be involved in the pathogenesis of IPF by being regulated by the FOXF1/R-Ras signalling, NFATc3 and in the pathogenesis of SSc by being a downstream signalling molecule with low NCF1 activity19–21. The gene discussed is CCL2; the disease is systemic sclerosis.